06.19.25 -- A Psychedelic Path To CDMO Selection?

Join KBI Biopharma for a webinar on transposase-enabled cell line development. Built on Selexis® SUREtechnology™ and CHO-M™, this platform delivers high titers, rapid development, and stability for complex biologics. Learn how it accelerates timelines, supports diverse molecule formats, and meets regulatory demands—offering a scalable, efficient alternative to traditional CLD methods. Perfect for teams seeking speed, quality, and flexibility in biotherapeutic development. Click here to learn more.

Explore innovative cell culture methodologies and bioreactor technologies to optimize productivity, enhance product quality, and drive efficiency in biotechnological applications.

While moving from early- to late-phase clinical trials is a critical milestone to celebrate on the way to commercialization, many face the same daunting question once the confetti settles ― now what?

Discover how spray drying can transform the formulation of complex biologics by improving stability, delivery, and functionality, with insights into the critical techniques needed for successful development.

CFPS use cell lysates or purified enzymes to synthesize proteins. They have emerged as a promising alternative to production with living cells.

Consider the importance of scalability and flexibility in the choice of an early-stage manufacturing strategy and how that decision impacts financial outcomes for a drug development program.

A challenge in drug development is finding a team that can carry a molecule from the research lab to the patient’s bedside. Witness three considerations that build a foundation for partnership.

Examine how advanced machine learning and data analytics are revolutionizing biopharmaceutical manufacturing and driving operational excellence.

Learn how a CMO can deliver significant value to drug developers by fostering successful outsourcing relationships, streamlining the path to market, and supporting demands.

Understand how using Protein A membrane and resin interchangeably can streamline bioprocessing for efficient, scalable, high-quality manufacturing from lab to full-scale production.

By leveraging our proprietary non-viral gene insertion technology, we ensure rapid development timelines and high-yield production, making an ideal solution for complex biologics.

Custom peptide synthesis services provide numerous options for synthesis platforms, purity levels, and modifications to meet a wide range of research needs.

Witness how an advanced CLD platform enables high-yield, stable CHO cell lines while overcoming bottlenecks and supporting verification, characterization, and monoclonality assessment.

Experience a global network of expertise and proven manufacturing capabilities that can help accelerate your clinical and commercial drug substance programs.